References
- Rong C, Lee Y, Carmona NE, et al. Cannabidiol in medical marijuana: research vistas and potential opportunities. Pharmacol Res. 2017;121:213–218.
- Park JY, Wu LT. Prevalence, reasons, perceived effects, and correlates of medical marijuana use: a review. Drug Alcohol Depend. 2017;177:1–13.
- The National Academies of Sciences E, and Medicine. The health effects of cannabis and cannabinoids. Washington (DC): THE NATIONAL ACADEMIES PRESS; 2017. [cited 2017 Aug 26].
- Murnion B. Medicinal cannabis. Aust Prescr. 2015;38(6):212–215.
- Cranford JA, Bohnert KM, Perron BE, et al. Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients. Drug Alcohol Depend. 2016;169:41–47.
- Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456–2473.
- Schauer GL, King BA, Bunnell RE, et al. Toking, vaping, and eating for health or fun: marijuana use patterns in adults, U.S., 2014. Am J Prev Med. 2016;50(1):1–8.
- Varlet V, Concha-Lozano N, Berthet A, et al. Drug vaping applied to cannabis: is “Cannavaping” a therapeutic alternative to marijuana? Sci Rep. 2016;6:25599.
- Lee DC, Crosier BS, Borodovsky JT, et al. Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend. 2016;159:227–233.
- Jorge LL, Feres CC, Teles VE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2010;4:11–24.
- Budney AJ, Sargent JD, Lee DC. Vaping cannabis (marijuana): parallel concerns to e-cigs? Addiction. 2015;110(11):1699–1704.
- Romano LL, Hazekamp A. Cannabis Oil: chemical evaluation of an upcoming cannabis-based medicine. Cannabinoids. 2013;1(1):1–11.
- Giroud C, de Cesare M, Berthet A, et al. E-Cigarettes: a review of new trends in cannabis use. Int J Environ Res Public Health. 2015;12(8):9988–10008.
- Malouff JM, Rooke SE, Copeland J. Experiences of marijuana-vaporizer users. Subst Abus. 2014;35(2):127–128.
- Cox B. Can the research community respond adequately to the health risks of vaping? Addiction. 2015;110(11):1708–1709.
- Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A. 2012;109(40):E2657–E2664.
- Gilman JM, Kuster JK, Lee S, et al. Cannabis use is quantitatively associated with nucleus accumbens and amygdala abnormalities in young adult recreational users. J Neurosci. 2014;34(16):5529–5538.
- World Health Organization. The health and social effects of nonmedical cannabis use. Geneva: World Health Organization; 2016. [cited 2017 Aug 26]. Available from: http://apps.who.int/iris/bitstream/10665/251056/1/9789241510240-eng.pdf?ua=1
- Grant KS, Petroff R, Isoherranen N, et al. Cannabis use during pregnancy: pharmacokinetics and effects on child development. Pharmacol Ther. 2017 Aug 25. pii: S0163-7258(17)30224-3. [Epub ahead of print]. DOI:10.1016/j.pharmthera.2017.08.014